LB748 - Efficacy And Safety Of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine In Older Adults

Thursday, October 20, 2022

2:21 PM – 2:33 PM US ET

Location: 209 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Presenting Author(s)

Edward E. Walsh, MD (he/him/his)

Professor of Medicine
University of Rochester
Rochester, NY, United States

Disclosure: Disclosure(s): Janssen: Honoraria (); Merck: Grant/Research Support (); Pfizer: Grant/Research Support ()

Co-Author(s)

FP

Fernando Polack, MD

Fundacion INFANT
Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina

Disclosure: Disclosure(s): I-trials: Ownership Interest (); Pfizer: Grant/Research Support ()
AZ

Agnieszka Zareba, MD PhD

Director Vaccines Research
Pfizer
Pearl RIver, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
Ann R. Falsey, MD

Dr
University of Rochester School of Medicine
Rochester, New York, United States

Disclosure: Disclosure(s): BioFire Diagnostics: Grant/Research Support (); Janssen: Grant/Research Support (); Merck Sharp & Dohme: Grant/Research Support (); Novavax: Advisor/Consultant (); Pfizer: Grant/Research Support ()
GP

Gonzalo Perez Marc, MD

CEO
i-trials
Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina

Disclosure: Disclosure(s): I-trials: Board Member (), Ownership Interest (); Pfizer: Grant/Research Support ()
QJ

Qin Jiang, PhD

Senior Director
Pfizer
Collegeville, Pennsylvania, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
KS

Kathy Schneider, PhD

Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
DC

David Cooper, PhD

Senior Director
Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
ML

Maria Maddalena Lino, PhD

Pfizer
Siena, Toscana, Italy

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
AA

Annaliesa S. Anderson, PhD

SVP & CSO
Pfizer
New York, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer (); Pfizer Inc: Employee (), Stocks/Bonds ()
KJ

Katherin U Jensen, PhD

Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
KS

Kena A. Swanson, Ph.D.

Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
AG

Alejandra C. Gurtman, M.D.

Vice President
Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
William C. Gruber, MD

SVP
Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer Inc: Employee (), Stocks/Bonds ()
BS

Beate Schmoele-Thoma, MD

Dr.
Pfizer
Pearl River, New York, United States

Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()

Disclosure(s):

Edward E. Walsh, MD: Janssen: Honoraria (); Merck: Grant/Research Support (); Pfizer: Grant/Research Support ()

Fernando Polack, MD: I-trials: Ownership Interest (); Pfizer: Grant/Research Support ()

Agnieszka Zareba, MD PhD: Pfizer: employee of Pfizer ()

Ann R. Falsey, MD: BioFire Diagnostics: Grant/Research Support (); Janssen: Grant/Research Support (); Merck Sharp & Dohme: Grant/Research Support (); Novavax: Advisor/Consultant (); Pfizer: Grant/Research Support ()

Gonzalo Perez Marc, MD: I-trials: Board Member (), Ownership Interest (); Pfizer: Grant/Research Support ()

Qin Jiang, PhD: Pfizer: employee of Pfizer ()

Kathy Schneider, PhD: Pfizer: employee of Pfizer ()

David Cooper, PhD: Pfizer: employee of Pfizer ()

Maria Maddalena Lino, PhD: Pfizer: employee of Pfizer ()

Annaliesa S. Anderson, PhD: Pfizer: employee of Pfizer (); Pfizer Inc: Employee (), Stocks/Bonds ()

Katherin U Jensen, PhD: Pfizer: employee of Pfizer ()

Kena A. Swanson, Ph.D.: Pfizer: employee of Pfizer ()

Alejandra C. Gurtman, M.D.: Pfizer: employee of Pfizer ()

William C. Gruber, MD: Pfizer Inc: Employee (), Stocks/Bonds ()

Beate Schmoele-Thoma, MD: Pfizer: employee of Pfizer ()